Fumimasa Nomura

Title: Fumimasa Nomura: Innovator in Cardiotoxicity Testing

Introduction

Fumimasa Nomura is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cardiotoxicity testing, holding three patents that focus on innovative methods and devices for evaluating cardiac health.

Latest Patents

Nomura's latest patents include a method and apparatus for testing cardiotoxicity and evaluating cardiomyocytes. This invention involves a cardiomyocyte cluster placed on a transparent substrate, allowing for the evaluation of cell quality through their response to a forced pulsation stimulus. The cardiomyocyte cluster is exposed to a liquid containing an agent, enabling the assessment of cardiac toxicity by measuring fluctuations between adjacent cardiomyocytes. Additionally, he has developed a device and method for examining myocardial toxicity that can be conducted in vitro, mimicking traditional in vivo assessments. This involves arranging a cell population as a pulsating pacemaker on a transparent substrate, where myocardial pulsating cells and fibroblast cells form a network. The cells are then exposed to a drug solution, allowing for the evaluation of QT delay caused by the drug.

Career Highlights

Throughout his career, Fumimasa Nomura has worked with notable institutions, including Tokyo Medical and Dental University and LSI Medience Corporation. His work has significantly advanced the understanding of cardiac health and toxicity.

Collaborations

Nomura has collaborated with esteemed colleagues such as Kenji Yasuda and Tomoyuki Kaneko, contributing to the development of innovative solutions in cardiotoxicity testing.

Conclusion

Fumimasa Nomura's contributions to the field of cardiotoxicity testing through his patents and collaborations highlight his role as a leading inventor in this critical area of medical research. His work continues to pave the way for advancements in cardiac health evaluation.